Insider · CIK 0001595064
Linda M Richardson
Files at ICPT (INTERCEPT PHARMACEUTICALS, INC.), ALT (Altimmune, Inc.). First filing -, latest -.
In brief
Linda M Richardson files SEC Form 4 as officer at ICPT (INTERCEPT PHARMACEUTICALS, INC.), and also at ALT (Altimmune, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Linda M Richardson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +24,000 | $0.00 | $0 | 24,000 | 26 d ago |
| Sep 16, 2026 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -6,826 | $3.24 | $22k | 17,174 | 26 d ago |
| Sep 16, 2026 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | -24,000 | $0.00 | $0 | 72,000 | 26 d ago |
| Sep 16, 2025 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +278,000 | $0.00 | $0 | 278,000 | Sep 17, 2025 |
| Sep 16, 2025 | ALT Altimmune, Inc. | AGrant or award Restricted Stock Unitsderivative | +96,000 | $0.00 | $0 | 96,000 | Sep 17, 2025 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | UTender of shares Common Stock | -16,706 | $19.00 | $317k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -26,585 | $19.00 | $505k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -17,600 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -20,000 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -3,912 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -8,368 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -5,000 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -5,896 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -9,500 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -8,500 | - | - | 0 | Nov 13, 2023 |
Questions about Linda M Richardson
Answered from the filings on this page, as of the latest one.
Is Linda M Richardson buying or selling?
Linda M Richardson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Linda M Richardson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Linda M Richardson has 0.
Where does Linda M Richardson file Form 4?
Linda M Richardson has filed Form 4 at ICPT (INTERCEPT PHARMACEUTICALS, INC.) as EVP & Chief Commercial Officer; ALT (Altimmune, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.